State-of-the-Art Review: Hepatitis CVincent Lo Re, Jessie Torgersen, Debika Bhattacharya et al.|Clinical Infectious Diseases|2025Cited by 3
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Sara Lodi, Robert Zangerle et al.|AIDS|2025Cited by 2
Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIVDaniela K van Santen, Sara Lodi, Mathieu Chalouni et al.|Clinical Infectious Diseases|2025Cited by 0
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIVMathieu Chalouni, Sara Lodi, Jessie Torgersen et al.|AIDS|2026Cited by 0
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.Mathieu Chalouni, Sara Lodi, Jessie Torgersen et al.|Open Access CRIS of the University of Bern|2026Cited by 0